# OCOG-ALMERA (NCT02115464)

> Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy

No report yet. It can be ordered.

- Drugs tested: metformin
- Indication: locally advanced non-small cell lung cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02115464
- Phase: PHASE2
- Status: TERMINATED
- Sponsor: Ontario Clinical Oncology Group (OCOG)
- Conditions: Lung Cancer
- Interventions: Metformin plus Chemo-radiotherapy; Chemo-radiotherapy
- Enrollment: 54
- Primary outcome: Progression free survival

## Indexed commentary on OCOG-ALMERA so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 4 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=ocog-almera-nct02115464